Literature DB >> 20144847

Dinuclear triphenylphosphinegold(I) sulfanylcarboxylates: Synthesis, structure and cytotoxic activity against cancer cell lines.

Elena Barreiro1, José S Casas, María D Couce, Agustín Sánchez, Angeles Sánchez-González, José Sordo, José M Varela, Ezequiel M Vázquez López.   

Abstract

Compounds of the type [(AuPPh(3))(2)(xspa)]; H(2)xspa [x:p=3-phenyl-, f=3-(2-furyl)-, t=3-(2-thienyl)-, -o-py=3-(2-pyridyl)-, Clp=3-(2-chlorophenyl)-, -o-mp=3-(2-methoxyphenyl)-, -p-mp=3-(4-methoxyphenyl)-, -o-hp=3-(2-hydroxyphenyl)-, -p-hp=3-(4-hydroxyphenyl)-, -diBr-o-hp=3-(3,5-dibromo-2-hydroxyphenyl)-; spa=2-sulfanyl propenoato] were synthesized and characterized by IR and NMR ((1)H, (13)C and (31)P) spectroscopy and by FAB mass spectrometry. The structures of [(AuPPh(3))(2)(Clpspa)], [(AuPPh(3))(2)(o-hpspa)], [(AuPPh(3))(2)(p-hpspa)].MeOH and [(AuPPh(3))(2)(diBr-o-hpspa)].2Me(2)CO show the dinuclear nature of the complexes with the two gold atoms, one of which is also O-bonded to an O atom of the carboxylate group, bonded to the S atom. The in vitro antitumor activities against the HeLa-229, A2780 and A2780cis cell lines were determined and the compounds were found to be highly effective, in particular against the A2780cis cell line, with eight of the nine compounds having IC(50) values better than that of cisplatin. This behavior is indicative of a high ability to circumvent the cellular resistance to this drug.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20144847     DOI: 10.1016/j.jinorgbio.2010.01.006

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  2 in total

1.  Relevance of Orbital Interactions and Pauli Repulsion in the Metal-Metal Bond of Coinage Metals.

Authors:  Maria B Brands; Jörn Nitsch; Célia Fonseca Guerra
Journal:  Inorg Chem       Date:  2018-02-12       Impact factor: 5.165

2.  Combined Effect of Caspase-Dependent and Caspase-Independent Apoptosis in the Anticancer Activity of Gold Complexes with Phosphine and Benzimidazole Derivatives.

Authors:  Lara Rouco; Ángeles Sánchez-González; Rebeca Alvariño; Amparo Alfonso; Ezequiel M Vázquez-López; Emilia García-Martínez; Marcelino Maneiro
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.